Intensity Therapeutics, Inc.(INTS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INTS Intensity Therapeutics, Inc.

盘前交易 11-03 04:37:33 EST

3.43

+0.03

+0.88%

最高3.50	最低3.23	成交量5,598
今开3.41	昨收3.40	日振幅7.91%
总市值1,120万	流通市值1,042万	总股本326.49万
成交额1.89万	换手率0.18%	流通股本303.89万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INTS","market":"US","secType":"STK","nameCN":"Intensity Therapeutics, Inc.","latestPrice":3.43,"timestamp":1793653200000,"preClose":3.4,"halted":0,"volume":5598,"delay":0,"changeRate":0.008823529411764779,"floatShares":3038900,"shares":3264900,"eps":-4.802551,"marketStatus":"盘前交易","change":0.03,"latestTime":"11-03 04:37:33 EST","open":3.41,"high":3.5,"low":3.2309,"amount":18947.953655999998,"amplitude":0.079147,"askPrice":5.3,"askSize":784,"bidPrice":2.75,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.802551,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793716200000},"marketStatusCode":1,"adr":0,"listingDate":1666324800000,"exchange":"NASDAQ","adjPreClose":3.43,"postHourTrading":{"tag":"盘后","latestPrice":3.41,"preClose":3.43,"latestTime":"19:30 EST","volume":203,"amount":692.03,"timestamp":1793665802922,"change":-0.02,"changeRate":-0.005831,"amplitude":0.005831},"volumeRatio":0.5512772514869035},"requestUrl":"/m/hq/s/INTS","defaultTab":"news","newsList":[{"id":"1132068598","title":"Intensity Therapeutics重启三阴性乳腺癌术前随机二期临床试验患者治疗（Invincible-4研究）","url":"https://stock-news.laohu8.com/highlight/detail?id=1132068598","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132068598?lang=zh_cn&edition=full","pubTime":"2026-07-15 19:47","pubTimestamp":1784116036,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics, Inc.已重新启动其针对三阴性乳腺癌的随机、术前二期临床试验的患者治疗工作。该试验代号为Invincible-4研究，旨在评估公司核心治疗方案在手术前治疗阶段的有效性与安全性。此次重启标志着临床试验进程步入关键阶段，为后续数据收集与分析奠定了重要基础。研究设计的随机性与术前干预特点，有望为三阴性乳腺癌这一治疗需求迫切的领域提供新的临床证据。公司方面表示，将严格遵循试验方案推进患者入组与治疗，并密切监测相关临床指标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196304113","title":"Intensity Therapeutics推进软组织肉瘤与术前三阴性乳腺癌的晚期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1196304113","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196304113?lang=zh_cn&edition=full","pubTime":"2026-07-01 20:08","pubTimestamp":1782907707,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics, Inc. 近日宣布，其在软组织肉瘤与术前三阴性乳腺癌两个关键领域的晚期临床研究取得了显著进展。针对软组织肉瘤，公司已成功推进其候选药物的后期临床试验阶段，为这一难治性癌症患者带来了新的希望。与此同时，在更具挑战性的三阴性乳腺癌领域，Intensity Therapeutics专注于术前治疗方案的开发，旨在通过新型疗法提高手术成功率并改善患者预后。这些进展不仅有望为患者提供更有效的治疗选择，也可能为Intensity Therapeutics的未来发展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153049206","title":"Intensity Therapeutics公司——Int230-6研究完成，患者入组超200例，成果经同行评审发表","url":"https://stock-news.laohu8.com/highlight/detail?id=1153049206","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153049206?lang=zh_cn&edition=full","pubTime":"2026-07-01 20:06","pubTimestamp":1782907604,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics公司宣布，其Int230-6相关研究已经完成，累计入组患者人数超过200名。该研究取得的成果现已通过严格的同行评审程序，并在专业学术期刊上正式发表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142253659","title":"Intensity Therapeutics发布年中进展，重点阐述Int230-6晚期研发项目与战略合作机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1142253659","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142253659?lang=zh_cn&edition=full","pubTime":"2026-07-01 20:03","pubTimestamp":1782907414,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics, Inc. 近日发布了其年中业务进展更新，重点聚焦于其核心候选药物Int230-6的晚期临床开发项目，并探讨了潜在的全球战略合作机遇。目前，多项晚期临床试验正在评估其在多种实体瘤中的疗效与安全性。Intensity Therapeutics重申了对推进其研发管线的承诺，并相信Int230-6有望成为肿瘤治疗领域的一个重要进展。公司将继续专注于执行其临床开发战略，同时探索所有可能的合作路径，以推动该创新疗法早日惠及患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518275867","title":"Intensity Therapeutics, Inc.盘中异动 股价大涨9.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518275867?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:25","pubTimestamp":1741616707,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时25分，Intensity Therapeutics, Inc.股票出现波动，股价急速拉升9.50%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222507a26a395a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222507a26a395a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INTS","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517288129","title":"Intensity Therapeutics, Inc.盘中异动 下午盘股价大涨7.24%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517288129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517288129?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:25","pubTimestamp":1741199118,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时25分，Intensity Therapeutics, Inc.股票出现波动，股价快速拉升7.24%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.34%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306022518a26107d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306022518a26107d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516630537","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大跌6.41%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516630537?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:51","pubTimestamp":1741013463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时51分，Intensity Therapeutics, Inc.股票出现异动，股价快速下挫6.41%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225103abe639c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225103abe639c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514090924","title":"Intensity Therapeutics, Inc.盘中异动 股价大涨8.68%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090924?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:33","pubTimestamp":1740494019,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时33分，Intensity Therapeutics, Inc.股票出现异动，股价大幅上涨8.68%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为760.40%、469.26%、243.33%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Dominari Holdings Inc.，振幅分别为20.51%、14.67%、11.73%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522333998924d2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522333998924d2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INTS","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513227057","title":"Intensity Therapeutics, Inc.盘中异动 早盘大幅拉升7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513227057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513227057?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:32","pubTimestamp":1740407559,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时32分，Intensity Therapeutics, Inc.股票出现异动，股价大幅上涨7.17%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242232399890f5c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242232399890f5c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INTS","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165996","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大涨8.06%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165996?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:37","pubTimestamp":1739889460,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时37分，Intensity Therapeutics, Inc.股票出现波动，股价快速上涨8.06%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182237409889fe1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182237409889fe1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511696256","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大涨7.37%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511696256?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:39","pubTimestamp":1739543980,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时39分，Intensity Therapeutics, Inc.股票出现异动，股价大幅拉升7.37%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422394196231d4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422394196231d4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511252075","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大涨7.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511252075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511252075?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:38","pubTimestamp":1739457481,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时38分，Intensity Therapeutics, Inc.股票出现波动，股价急速上涨7.51%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223801a244acc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223801a244acc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INTS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510518866","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大涨10.90%报2.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510518866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510518866?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:32","pubTimestamp":1739197934,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时32分，Intensity Therapeutics, Inc.股票出现波动，股价快速上涨10.90%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223214a240a224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223214a240a224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INTS","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509774952","title":"Intensity Therapeutics, Inc.盘中异动 快速跳水5.11%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509774952?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:32","pubTimestamp":1738852350,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时32分，Intensity Therapeutics, Inc.股票出现波动，股价大幅跳水5.11%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223230abc4d4c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223230abc4d4c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508992457","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大涨6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508992457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508992457?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:31","pubTimestamp":1738679489,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时31分，Intensity Therapeutics, Inc.股票出现异动，股价大幅拉升6.51%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Azitra Inc、Evaxion Biotech As、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为834.81%、673.74%、185.13%，振幅较大的相关个股有Omega Therapeutics, Inc.、Azitra Inc、Evaxion Biotech As，振幅分别为17.57%、13.82%、8.75%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223130987a4a5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223130987a4a5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508129149","title":"Intensity Therapeutics, Inc.盘中异动 大幅上涨7.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508129149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508129149?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:37","pubTimestamp":1738593423,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时37分，Intensity Therapeutics, Inc.股票出现波动，股价快速拉升7.24%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223703a2380b1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223703a2380b1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507621301","title":"Intensity Therapeutics, Inc.盘中异动 股价大涨6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507621301?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:37","pubTimestamp":1738247863,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时37分，Intensity Therapeutics, Inc.股票出现异动，股价快速拉升6.34%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223744abbd4d80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223744abbd4d80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506392514","title":"Intensity Therapeutics, Inc.股价拉升10.34% 市值涨15.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506392514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506392514?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:37","pubTimestamp":1738075026,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时37分，Intensity Therapeutics, Inc.股票出现异动，股价快速拉升10.34%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822370698756c50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822370698756c50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INTS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506300645","title":"Intensity Therapeutics, Inc.盘中异动 股价大跌8.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506300645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506300645?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:06","pubTimestamp":1737997567,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时06分，Intensity Therapeutics, Inc.股票出现波动，股价急速下跌8.19%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应，不仅攻击注射的肿瘤，还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280106089612510c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280106089612510c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INTS","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505615828","title":"Intensity Therapeutics, Inc.盘中异动 股价大跌5.58%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505615828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505615828?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:40","pubTimestamp":1737729604,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时40分，Intensity Therapeutics, Inc.股票出现波动，股价急速跳水5.58%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Pmgc Holdings Inc.、Evaxion Biotech As、Transcode Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Avenue Therapeutics, Inc.较为活跃，换手率分别为2165.50%、1323.58%、854.61%，振幅较大的相关个股有Pmgc Holdings Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.，振幅分别为40.91%、35.16%、29.96%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124224004960f8eff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124224004960f8eff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INTS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.intensitytherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":-0.0029},{"period":"3month","weight":-0.1794},{"period":"6month","weight":-0.3417},{"period":"1year","weight":-0.8121},{"period":"ytd","weight":-0.6655}],"compareEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0228},{"period":"3month","weight":-0.0249},{"period":"6month","weight":0.0249},{"period":"1year","weight":0.1027},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Intensity Therapeutics, Inc.于2012年11月30日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，开创了一种新的基于免疫的方法来治疗实体瘤癌症。该公司利用其DfuseRx技术平台创造专利药物配方，直接注射后迅速扩散到整个肿瘤，并将治疗剂扩散到癌细胞中。该公司的候选产品有可能诱导一种适应性免疫反应，不仅可以攻击注射的肿瘤，还可以攻击未注射的肿瘤。该公司的主要候选产品INT230-6正在开发中，用于治疗实体瘤患者，如肉瘤和乳腺癌患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.092983},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.117023},{"month":3,"riseRate":0.333333,"avgChangeRate":0.00497},{"month":4,"riseRate":0,"avgChangeRate":-0.355139},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.025002},{"month":6,"riseRate":0,"avgChangeRate":-0.1447},{"month":7,"riseRate":0.25,"avgChangeRate":-0.034509},{"month":8,"riseRate":0.75,"avgChangeRate":-0.014998},{"month":9,"riseRate":0,"avgChangeRate":-0.193171},{"month":10,"riseRate":0.5,"avgChangeRate":0.407904},{"month":11,"riseRate":0.25,"avgChangeRate":-0.183834},{"month":12,"riseRate":0.666667,"avgChangeRate":0.708682}],"exchange":"NASDAQ","name":"Intensity Therapeutics, Inc.","nameEN":"Intensity Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Intensity Therapeutics, Inc.(INTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Intensity Therapeutics, Inc.(INTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Intensity Therapeutics, Inc.,INTS,Intensity Therapeutics, Inc.股票,Intensity Therapeutics, Inc.股票老虎,Intensity Therapeutics, Inc.股票老虎国际,Intensity Therapeutics, Inc.行情,Intensity Therapeutics, Inc.股票行情,Intensity Therapeutics, Inc.股价,Intensity Therapeutics, Inc.股市,Intensity Therapeutics, Inc.股票价格,Intensity Therapeutics, Inc.股票交易,Intensity Therapeutics, Inc.股票购买,Intensity Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Intensity Therapeutics, Inc.(INTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Intensity Therapeutics, Inc.(INTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}